30 related articles for article (PubMed ID: 351717)
1. Ultrasound and magnetic resonance imaging-based investigation of the role of perfusion and oxygen availability in menstrual pain.
Cockrum RH; Tu FF; Kierzkowska O; Leloudas N; Pottumarthi PV; Hellman KM
Am J Obstet Gynecol; 2024 May; 230(5):553.e1-553.e14. PubMed ID: 38295969
[TBL] [Abstract][Full Text] [Related]
2. Association of fish intake with menstrual pain: A cross-sectional study of the Japan Environment and Children's Study.
Yokoyama E; Takeda T; Watanabe Z; Iwama N; Satoh M; Murakami T; Sakurai K; Shiga N; Tatsuta N; Saito M; Tachibana M; Arima T; Kuriyama S; Metoki H; Yaegashi N
PLoS One; 2022; 17(7):e0269042. PubMed ID: 35862448
[TBL] [Abstract][Full Text] [Related]
3. Nonsteroidal anti-inflammatory drugs for dysmenorrhoea.
Marjoribanks J; Ayeleke RO; Farquhar C; Proctor M
Cochrane Database Syst Rev; 2015 Jul; 2015(7):CD001751. PubMed ID: 26224322
[TBL] [Abstract][Full Text] [Related]
4. Statistical analysis of shear wave speed in the uterine cervix.
Carlson LC; Feltovich H; Palmeri ML; del Rio AM; Hall TJ
IEEE Trans Ultrason Ferroelectr Freq Control; 2014 Oct; 61(10):1651-60. PubMed ID: 25392863
[TBL] [Abstract][Full Text] [Related]
5. Nimesulide in dysmenorrhoea.
Pulkkinen M
Drugs; 1993; 46 Suppl 1():129-33. PubMed ID: 7506151
[TBL] [Abstract][Full Text] [Related]
6. Potential therapeutic applications of aspirin and other cyclo-oxygenase inhibitors.
Farah AE; Rosenberg F
Br J Clin Pharmacol; 1980 Oct; 10 Suppl 2(Suppl 2):261S-278S. PubMed ID: 6776977
[TBL] [Abstract][Full Text] [Related]
7. Contribution to the pathogenesis of dysmenorrhea.
Zahradnik HP; Breckwoldt M
Arch Gynecol; 1984; 236(2):99-108. PubMed ID: 6596911
[TBL] [Abstract][Full Text] [Related]
8. Naproxen up to date: a review of its pharmacological properties and therapeutic efficacy and use in rheumatic diseases and pain states.
Brogden RN; Heel RC; Speight TM; Avery GS
Drugs; 1979 Oct; 18(4):241-77. PubMed ID: 387372
[TBL] [Abstract][Full Text] [Related]
9. A rationale for the treatment of dysmenorrhea.
Csapo AI
J Reprod Med; 1980 Oct; 25(4 Suppl):213-21. PubMed ID: 7001020
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of the use of sumatriptan-naproxen sodium for menstrual migraine and dysmenorrhea.
Allais G; Castagnoli Gabellari I; Rolando S; Benedetto C
Expert Rev Neurother; 2011 Oct; 11(10):1383-7. PubMed ID: 21955195
[TBL] [Abstract][Full Text] [Related]
11. The effect of naproxen-sodium on the prostaglandin concentrations of the menstrual blood and uterine "jet-washings" in dysmenorrheic women.
Pulkkinen MO; Henzl MR; Csapo AI
Prostaglandins; 1978 Mar; 15(3):543-50. PubMed ID: 351717
[No Abstract] [Full Text] [Related]
12. [Prostaglandins and dysmenorrhea effect of naproxen on prostaglandin concentrations in menstrual blood (author's transl)].
Ninagawa T; Matsukawa R; Yoshio T; Kan S; Ito K
Acta Obstet Gynaecol Jpn; 1981 Apr; 33(4):449-54. PubMed ID: 7234342
[TBL] [Abstract][Full Text] [Related]
13. Effects of naproxen sodium on menstrual prostaglandins and primary dysmenorrhea.
Chan WY; Fuchs F; Powell AM
Obstet Gynecol; 1983 Mar; 61(3):285-91. PubMed ID: 6571974
[TBL] [Abstract][Full Text] [Related]
14. Effect of ibuprofen on menstrual blood prostaglandin levels in dysmenorrheic women.
Pulkkinen MO; Csapo AI
Prostaglandins; 1979 Jul; 18(1):137-42. PubMed ID: 392621
[TBL] [Abstract][Full Text] [Related]
15. Endogenous prostaglandins in dysmenorrhea and the effect of prostaglandin synthetase inhibitors (PGSI) on uterine contractility.
Lundström V; Gréen K; Svanborg K
Acta Obstet Gynecol Scand Suppl; 1979; 87():51-6. PubMed ID: 111466
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
